Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             24 results found
no title author magazine year volume issue page(s) type
1 A cautionary tale: Is this APOB whole-gene duplication actually pathogenic? Lazarte, Julieta

14 5 p. 631-635
article
2 Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity Levine, Jordan A.

14 5 p. 667-674
article
3 Bempedoic acid: A new player in lipid-lowering therapies Cuevas, Ada

14 5 p. 615-616
article
4 Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials Bays, Harold E.

14 5 p. 649-659.e6
article
5 Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 Defesche, Joep C.

14 5 p. 742
article
6 “Corrigendum to Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study” Journal of Clinical Lipidology Volume 12, Issue 3, May–June 2018, Pages 718-727.e6 Harris, William S.

14 5 p. 740
article
7 Corrigendum to PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study Volume 14, Issue 3, May–June 2020, Pages 322-330.e5 Daniels, Stephen

14 5 p. 741
article
8 Editorial Board
14 5 p. A1-A4
article
9 Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia Mohebi, Reza

14 5 p. 636-638
article
10 From the editor: Connectedness and lipidology Guyton, John R.

14 5 p. 611
article
11 From the President of the International Atherosclerosis Society Santos, Raul D.

14 5 p. 613-614
article
12 Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort Brandt, Eric J.

14 5 p. 695-706.e4
article
13 Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study Tanner, Rikki M.

14 5 p. 720-729
article
14 Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis McComb, Mason

14 5 p. 675-684.e2
article
15 News from the NLA
14 5 p. 612
article
16 Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial Roth, Eli M.

14 5 p. 707-719
article
17 Preβ1-high-density lipoprotein metabolism is delayed in patients with chronic kidney disease not on hemodialysis Yamatani, Kotoko

14 5 p. 730-739
article
18 Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia Vuorio, Alpo

14 5 p. 617-618
article
19 Successful pharmacological management of a child with compound heterozygous familial hypercholesterolemia and review of the recent literature Sreedharan, Aravind Venkatesh

14 5 p. 639-645
article
20 Successful treatment of a patient with mitochondrial myopathy with alirocumab Cicero, Arrigo F.G.

14 5 p. 646-648
article
21 Table of Contents
14 5 p. A5-A7
article
22 The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia Paquette, Martine

14 5 p. 660-666
article
23 Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: Does level of endogenous estradiol matter? The SWAN HDL Ancillary Study Nasr, Alexis

14 5 p. 685-694.e2
article
24 Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability Nidorf, Stefan Mark

14 5 p. 619-630
article
                             24 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands